DOES ULTRAVIOLET-EVOKED PROSTAGLANDIN FORMATION PROTECT SKIN FROM ACTINIC CANCER?
- 31 December 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 311 (8057), 189
- https://doi.org/10.1016/s0140-6736(78)90618-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Letter: Chromosome damage produced by psoralen and ultraviolet light.BMJ, 1976
- Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet LightNew England Journal of Medicine, 1974
- Possible involvement of cyclic GMP in growth control of cultured mouse cellsNature, 1974
- Defects and deficiency of adenyl cyclase in psoriatic skinArchives of Dermatology, 1973
- Guanosine 3′:5′-Cyclic Monophosphate: A Possible Intracellular Mediator of Mitogenic Influences in LymphocytesProceedings of the National Academy of Sciences, 1972
- Decreased cyclic AMP in the epidermis of lesions of psoriasisArchives of Dermatology, 1972
- Difference in the Cyclic Adenosine 3′,5′-Monophosphate Levels in Normal and Transformed CellsNature New Biology, 1972
- Pharmacologic Agents Released in Ultraviolet Inflammation Studied by Continuous Skin PerfusionJournal of Investigative Dermatology, 1970
- Mutagenesis in Escherichia coli IV. Photosensitization to near ultraviolet light by 8-methoxypsoralenMutation Research, 1970